Herantis Pharma strengthens team - Outi Lahdenperä and Antti Vuolanto have joined Herantis
Herantis Pharma strengthens team - Outi Lahdenperä and Antti Vuolanto have joined Herantis Herantis Pharma PlcPress release 12 Feb 2018 at 9:00 am Herantis Pharma plc ("Herantis") has strengthened its core team with two experienced drug development professionals. Docent Outi Lahdenperä, MD, PhD, has joined Herantis as part-time Chief Medical Officer for Lymfactin® development; and Dr. Antti Vuolanto, DSc, has joined Herantis as Chief Operating Officer. "We are really pleased to have two such highly valued senior experts join our team", says Pekka Simula, Herantis' CEO. "The